NCT06217900View on ClinicalTrials.gov

a PROspective Case Control Study to Develop and Validate a Blood Test FOr mUlti-caNcers Early Detection（PROFOUND）

RecruitingOBSERVATIONAL
Enrollment

16,666

Participants

Timeline

Start Date

December 28, 2023

Primary Completion Date

October 31, 2026

Study Completion Date

March 31, 2027

Conditions
Cancer
Trial Locations (2)

100044

RECRUITING

Peking University People's Hospital, Beijing

100083

NOT_YET_RECRUITING

Peking University Cancer Hospital and Institute, Beijing

All Listed Sponsors
collaborator

Peking University People's Hospital

OTHER

lead

Shanghai Weihe Medical Laboratory Co., Ltd.

INDUSTRY